Home > Insider Trading > Filing (0000921895-10-001596)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1043914	Ore Pharmaceutical Holdings Inc.	ORXE.PK	In Vitro & In Vivo Diagnostic Substances (2835)	061411336

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1005784	G Warren Lichtenstein	C/O Steel Partners Holdings L.p. 590 Madison Avenue, 32Nd Floor New York NY 10022		No	No	Yes	No
1504325	Steel Partners, Ltd.	590 Madison Avenue, 32Nd Floor New York NY 10022		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $.01 Par Value	Acquisiton	2010-10-27	125,000	$0.26	3,500,000	No	4	P	Direct
Common Stock, $.01 Par Value	Acquisiton	2010-10-28	68,000	$0.26	3,568,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

This Form 4 is filed jointly by Steel Partners, Ltd. ("SPL") and Warren G. Lichtenstein. Mr. Lichtenstein may be deemed to be a 10% owner of the Issuer and SPL is a 10% owner of the Issuer.
The securities reported in this Form 4 are owned directly by SPL, and owned indirectly by Mr. Lichtenstein by virtue of his position as the Chief Executive Officer and sole Director of SPL. Mr. Lichtenstein disclaims beneficial ownership of the shares owned by SPL except to the extent of his pecuniary interest therein.